Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Retin Cases Brief Rep. 2016 Fall;10(4):357–360. doi: 10.1097/ICB.0000000000000262

Figure 1.

Figure 1

Patient 1 showing response of retinal disease to intravitreal melphalan. Left: Left eye of patient 1 showing pre/peripapillary tumor recurrence following a treatment course of systemic chemotherapy, laser and four courses of ophthalmic artery chemosurgery (OAC) (8 infusions). Right: Left eye of patient 1 with tumor regression following 8 injections of intravitreal melphalan.